KOSDAQ · Healthcare · ₩260B
₩2,755-3.16%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 5.0% · as of 26.09.11
Among 36 신약 개발 peers
Quarterly Revenue Growth
“이번 분기는 연구 성과가 다음 성장의 문을 여는 때예요.”
In the company's words · 2026 2분기 filing